4[3]Spahn TW,Eugster HP,Fontana A,et al.Role of lymphotoxin in experimental models of infectious diseases:potential benefits and risks of a therapeutic inhibition of the 1ymphotoxin-beta receptor pathway[J].Infect Immun,2005,73(11):7077-7088.
5[4]Ozaki K,Inoue K,Sato H,et al.Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro[J].Nature,2004,429(6987):72-75.
6[5]Ozaki K,Ohnishi Y.Iida A,et al.Functional SNPs in the 1ymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction[J].Nat Genet,2002,32(4):650-654.
7[6]Mizuno H,Sato H,Sakata Y,et al.Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction[J].Atheroselerosis,2006,185(2):400-405.
8[7]PROCARDIS Consortium.A trio family study showing association of the lymphotoxin-alpha N26(804A)allele with coronary artery disease[J].Eur J Hum Genet,2004,12(9):770-774.
9[8]Laxton R,Pearce E,Kyriakou T,et al.Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary athcrosclcrosis[J].Genes Immun,2005,6(6):539-541.
10[9]Suzuki G,Izumi S,Hakoda M,et al.LTA 252(;allelecontaining haplotype block is associated with high serum C-reactive protein levels[J].Atherosclerosis,2004,176 (1):91-94.
1Liu L, Ding W, Zhao F, et al .Plasma levels and potential roles of catestatin in patients with coronary heart disease[J]. Scand Cardiovasc J, 2013,47(4)~217-224.
2Zhu D, Wang F, Yu H, et al .Catestatin is useful in detec- ting patients with stage B heart failure[J]. Biomarkers, 2011, 16(8) :691-697.
